139 related articles for article (PubMed ID: 24000140)
1. Effects of preoperative leukocytapheresis on inflammatory cytokines following surgery for ulcerative colitis: a prospective randomized study.
Bamba T; Yamamoto T; Umegae S; Matsumoto K
J Clin Apher; 2014 Apr; 29(2):107-12. PubMed ID: 24000140
[TBL] [Abstract][Full Text] [Related]
2. The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis.
Toya Y; Chiba T; Mizutani T; Sato K; Kasugai S; Matsuda N; Orikasa S; Shibata S; Abiko Y; Akasaka R; Yokoyama N; Oana S; Hirota S; Endo M; Suzuki K
Cytokine; 2013 Apr; 62(1):146-50. PubMed ID: 23465691
[TBL] [Abstract][Full Text] [Related]
3. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
[TBL] [Abstract][Full Text] [Related]
4. Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis.
Andoh A; Ogawa A; Kitamura K; Inatomi O; Fujino S; Tsujikawa T; Sasaki M; Mitsuyama K; Fujiyama Y
J Gastroenterol; 2004 Dec; 39(12):1150-7. PubMed ID: 15622478
[TBL] [Abstract][Full Text] [Related]
5. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
7. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
Schultheiß C; Weischenberg R; Herrmann A; Haller B; Schmid RM; Reindl W; Huber W
Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
[TBL] [Abstract][Full Text] [Related]
8. Effect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitis.
Nakamura T; Kawagoe Y; Matsuda T; Ueda A; Ueda Y; Takahashi Y; Tanaka A; Koide H
Blood Purif; 2004; 22(6):499-504. PubMed ID: 15528877
[TBL] [Abstract][Full Text] [Related]
9. Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8, and expression of Toll-like receptor 2 on granulocytes.
Aoki H; Nakamura K; Yoshimatsu Y; Tsuda Y; Irie M; Fukuda K; Hosoe N; Takada N; Shirai K; Suzuki Y
Dig Dis Sci; 2007 Jun; 52(6):1427-33. PubMed ID: 17394078
[TBL] [Abstract][Full Text] [Related]
10. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.
Sacco R; Tanaka T; Yamamoto T; Bresci G; Saniabadi AR
Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):327-33. PubMed ID: 25160857
[TBL] [Abstract][Full Text] [Related]
11. Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
Sakimura K; Omori T; Iwashita E; Yoshida T; Tsuzuki Y; Fujimori K; Konishi F; Yoshida Y; Anzai H; Suzuki H; Sugawara S; Takeda Y; Hiraishi K; Saniabadi AR; Ide T; Miura S; Ota S
Dig Dis Sci; 2006 Sep; 51(9):1525-31. PubMed ID: 16902810
[TBL] [Abstract][Full Text] [Related]
12. Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines.
Beltrán B; Sáez-González E; Moret I; Díaz-Jaime FC; Alvarez-Sotomayor D; Cerrillo E; Iborra M; Bastida G; Aguas M; Nos P
J Clin Apher; 2018 Feb; 33(1):99-103. PubMed ID: 28485025
[TBL] [Abstract][Full Text] [Related]
13. Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis.
Hanai H; Iida T; Yamada M; Sato Y; Takeuchi K; Tanaka T; Kondo K; Kikuyama M; Maruyama Y; Iwaoka Y; Nakamura A; Hirayama K; Saniabadi AR; Watanabe F
World J Gastroenterol; 2006 Jun; 12(21):3393-9. PubMed ID: 16733857
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
[TBL] [Abstract][Full Text] [Related]
15. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings.
Yamamoto T; Saniabadi AR; Umegae S; Matsumoto K
Inflamm Bowel Dis; 2006 Aug; 12(8):719-26. PubMed ID: 16917227
[TBL] [Abstract][Full Text] [Related]
16. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
[TBL] [Abstract][Full Text] [Related]
17. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis.
Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Saniabadi A
Am J Gastroenterol; 2004 Aug; 99(8):1532-8. PubMed ID: 15307873
[TBL] [Abstract][Full Text] [Related]
18. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.
Hanai H
World J Gastroenterol; 2006 Dec; 12(47):7568-77. PubMed ID: 17171783
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.
Yokoyama Y; Fukunaga K; Fukuda Y; Tozawa K; Kamikozuru K; Ohnishi K; Kusaka T; Kosaka T; Hida N; Ohda Y; Miwa H; Matsumoto T
Dig Dis Sci; 2007 Oct; 52(10):2725-31. PubMed ID: 17404876
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of long-term function, complications, quality of life and health status after restorative proctocolectomy with ileo neo rectal and with ileal pouch anal anastomosis for ulcerative colitis.
Heikens JT; de Vries J; de Jong DJ; den Oudsten BL; Hopman W; Groenewoud JM; van der Kolk MB; Gooszen HG; van Laarhoven CJ
Colorectal Dis; 2013 Jun; 15(6):e323-9. PubMed ID: 23406347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
